Hester Biosciences Limited Board Approves Re-classification Submission for Promoters
Hester Biosciences Limited announced on May 15, 2026, that its Board of Directors approved the submission of an application to the listed stock exchanges, the National Stock Exchange of India Limited and BSE Limited. This submission pertains to obtaining a No Objection Certificate for the re-classification of shares held by certain promoter shareholders.The board meeting addressed the earlier requests received from Mr. Ravin Gandhi and Ms. Bela Gandhi, both associated with the promoter group.
In confirming the status of the promoter shareholders, the company noted that Mr. Ravin Gandhi and Ms. Bela Gandhi confirmed their satisfaction of the specified conditions. They further confirmed their continued compliance with the necessary requirements regarding their shareholdings.
The re-classification remains subject to receiving no objection from the respective stock exchanges, which is a required step for the process to be completed.
HESTERBIO Stock Price Movement
Shares of Hester Biosciences Limited are edging higher to ₹1945 as of 12:56 PM today, having gained 11.77% in live trading. The equity sees robust activity, with a total volume of 130,783 shares processed so far.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.